Product
WCK 4282
1 clinical trial
2 indications
Indication
Complicated UTIIndication
PyelonephritisClinical trial
A Phase III, Randomized, Double-Blind, Multicenter, Comparative Study to Determine the Efficacy and Safety of Cefepime-Tazobactam vs. Meropenem Followed by Optional Oral Therapy in the Treatment of Complicated Urinary Tract Infection or Acute Pyelonephritis in AdultsStatus: Not yet recruiting, Estimated PCD: 2026-01-01